Akt Enhances Mdm2-mediated Ubiquitination and Degradation of p53

Ogawara, Yoko, Kishishita, Shohei, Obata, Toshiyuki, Isazawa, Yuko, Suzuki, Toshiaki, Tanaka, Keiji, Masuyama, Norihisa, Gotoh, Yukiko·2002·Journal of Biological Chemistry
DOI 10.1074/jbc.m109745200

Cited by (617)

Items 101–200 of 617

  1. Lenalidomide promotes p53 degradation by inhibiting MDM2 auto-ubiquitination in myelodysplastic syndrome with chromosome 5q deletion
    Sheng Wei, X Chen, Kathy L. McGraw, Ling Zhang, Rami S. Komrokji, Justine Clark, Gisela Cáceres, Debbie Billingsley, Lubomir Sokol, Jeffrey E. Lancet et al. · 2012 · Oncogene
  2. Wheat phenolics suppress doxorubicin-induced cardiotoxicity via inhibition of oxidative stress, MAP kinase activation, NF-κB pathway, PI3K/Akt/mTOR impairment, and cardiac apoptosis
    Ranabir Sahu, Tarun Kumar Dua, Sonjit Das, Vincenzo De Feo, Saikat Dewanjee · 2019 · Food and Chemical Toxicology
  3. PTEN Regulates Mdm2 Expression through the P1 Promoter
    Chun-Ju Chang, Daniel J. Freeman, Hong Wu · 2004 · Journal of Biological Chemistry
  4. Molecular Aspects of the Stress Response: Chaperones, Membranes and Networks
    Péter Csermely, László Vígh · 2007 · Springer eBooks
  5. New Insights in Thyroid Cancer and p53 Family Proteins
    Livia Manzella, Stefania Stella, Maria Stella Pennisi, Elena Tirrò, Michele Massimino, Chiara Romano, Adriana Puma, Martina Tavarelli, Paolo Giovanni Vigneri · 2017 · International Journal of Molecular Sciences
  6. Novel Somatic Mutations to PI3K Pathway Genes in Metastatic Melanoma
    Austin Young Shull, Alicia Latham-Schwark, Poornema Ramasamy, Kristin L. Leskoske, Dora Oroian, Marc R. Birtwistle, Phillip Buckhaults · 2012 · PLoS ONE
  7. Onzin, a c-Myc-repressed target, promotes survival and transformation by modulating the Akt–Mdm2–p53 pathway
    Kenneth R. Rogulski, Youjun Li, Kristi D. Rothermund, Lixia Pu, Simon C. Watkins, Fenghua Yi, Edward V. Prochownik · 2005 · Oncogene
  8. Caveolin and cavin family members: Dual roles in cancer
    Reeshu Gupta, Chirine Toufaily, Borhane Annabi · 2014 · Biochimie
  9. Abrogation of Akt signaling by Isobavachalcone contributes to its anti-proliferative effects towards human cancer cells
    Hui Jing, Xinglu Zhou, Xiaowu Dong, Ji Cao, Hong Zhu, Jian-Shu Lou, Yongzhou Hu, Qiaojun He, Bo Yang · 2010 · Cancer Letters
  10. TIGAR, TIGAR, burning bright
    Pearl Lee, Karen H. Vousden, Eric C. Cheung · 2014 · Cancer & Metabolism
  11. Functional role of Mdm2 phosphorylation by ATR in attenuation of p53 nuclear export
    Shinozaki, Tomomi, Nota, Ayumi, Taya, Yoichi, Okamoto, Koji · 2003 · Oncogene
  12. Statins induce mammalian target of rapamycin (mTOR)-mediated inhibition of Akt signaling and sensitize p53-deficient cells to cytostatic drugs
    Emilie Annie Roudier, Oras Mistafa, Ulla Stenius · 2006 · Molecular Cancer Therapeutics
  13. Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum
    Ahmed Ali, Lee Farrand, Ji Young Kim, Sanguine Byun, Jeong‐Yong Suh, Hyong Joo Lee, Benjamin K. Tsang · 2012 · Annals of the New York Academy of Sciences
  14. Cell differentiation versus cell death: extracellular glucose is a key determinant of cell fate following oxidative stress exposure
    Raewyn C. Poulsen, Helen J. Knowles, A J Carr, P A Hulley · 2014 · Cell Death and Disease
  15. Roles of the PI3K/Akt pathway and autophagy in TLR3 signaling-induced apoptosis and growth arrest of human prostate cancer cells
    Nanae Harashima, Tohko Inao, Ryu Imamura, Shinji Okano, Takashi Suda, Mamoru Harada · 2011 · Cancer Immunology Immunotherapy
  16. The Inhibitory Mechanisms of Tumor PD-L1 Expression by Natural Bioactive Gallic Acid in Non-Small-Cell Lung Cancer (NSCLC) Cells
    Dong Young Kang, Nipin Sp, Eun Seong Jo, Alexis Rugamba, Dae Young Hong, Mark Hong Lee, Ji‐Seung Yoo, Qing Liu, Kyoung‐Jin Jang, Young Mok Yang · 2020 · Cancers
  17. Elevated Levels of Oncogenic Protein Kinase Pim-1 Induce the p53 Pathway in Cultured Cells and Correlate with Increased Mdm2 in Mantle Cell Lymphoma
    Carol Hogan, Caroline Hutchison, Lynnette Marcar, Diane Milne, Mark K. Saville, John R. Goodlad, Neil Kernohan, David W. Meek · 2008 · Journal of Biological Chemistry
  18. DNA Damage–Induced Protein 14-3-3 σ Inhibits Protein Kinase B/Akt Activation and Suppresses Akt-Activated Cancer
    Huiling Yang, Yu-Ye Wen, Ruiying Zhao, Yu‐Li Lin, Keith F. Fournier, Heng-Yin Yang, Yun Qiu, José I. Diaz, Christine Laronga, Mong‐Hong Lee · 2006 · Cancer Research
  19. A component of the mir-17-92 polycistronic oncomir promotes oncogene-dependent apoptosis
    Virginie Olive, Erich Y. Sabio, Margaux J. Bennett, Caitlin S De Jong, Anne Biton, James C. McGann, Samantha K. Greaney, Nicole M. Sodir, Alicia Yiran Zhou, Asha Balakrishnan et al. · 2013 · eLife
  20. Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells
    Michael E. Fraser, Siu‐Lung Chan, S S L Chan, Ronald R. Fiscus, Benjamin K. Tsang · 2005 · Oncogene
  21. SCF E3 ligase F‐box protein complex SCF FBXL19 regulates cell migration by mediating Rac1 ubiquitination and degradation
    Jing Zhao, Rachel K. Mialki, Jianxin Wei, Tiffany A. Coon, Chunbin Zou, Bill B. Chen, Rama K. Mallampalli, Yutong Zhao · 2013 · The FASEB Journal
  22. Arsenic trioxide induces apoptosis and G2/M phase arrest by inducing Cbl to inhibit PI3K/Akt signaling and thereby regulate p53 activation
    Yingchun Li, Xiujuan Qu, Jinglei Qu, Ye Zhang, Jing Liu, Yuee Teng, Xuejun Hu, Kezuo Hou, Yunpeng Liu · 2009 · Cancer Letters
  23. Phosphorylation of MDMX Mediated by Akt Leads to Stabilization and Induces 14-3-3 Binding
    Lopez-Pajares, Vanessa, Kim, Mihee M., Yuan, Zhi-Min · 2008 · Journal of Biological Chemistry
  24. TRAF6 Restricts p53 Mitochondrial Translocation, Apoptosis, and Tumor Suppression
    Xian Zhang, Chien‐Feng Li, Ling Zhang, Ching‐Yuan Wu, Lixia Han, Guoxiang Jin, Abdol Hossein Rezaeian, Fei Han, Chunfang Liu, Chuan Shan Xu et al. · 2016 · Molecular Cell
  25. SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival
    Nina Fenouille, Alexandre Puissant, Mélanie Tichet, Geordie Zimniak, Patricia Abbe, Aude Mallavialle, Stéphane Rocchi, J.‐P. Ortonne, Marcel Deckert, Robert Ballotti et al. · 2011 · Oncogene
  26. p53 Is a Key Molecular Target of Ursodeoxycholic Acid in Regulating Apoptosis
    Joana D. Amaral, Rui Eduardo Castro, Susana Solá, Clifford J. Steer, Cecília M. P. Rodrigues · 2007 · Journal of Biological Chemistry
  27. Enterolactone induces apoptosis in human prostate carcinoma LNCaP cells via a mitochondrial-mediated, caspase-dependent pathway
    Lihua Chen, Jing Susan Fang, Huaixing Li, Wendy Demark‐Wahnefried, Xu Lin · 2007 · Molecular Cancer Therapeutics
  28. p53 protects against LPS-induced lung endothelial barrier dysfunction
    Nektarios Barabutis, Christiana Dimitropoulou, Charalampos Birmpas, Atul Joshi, Gagan Singh Thangjam, John D. Catravas · 2015 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  29. The regulation of MDM2 by multisite phosphorylation—opportunities for molecular-based intervention to target tumours?
    Meek, David W., Hupp, Ted R. · 2010 · Seminars in Cancer Biology
  30. BRCA1 at the crossroad of multiple cellular pathways: approaches for therapeutic interventions
    Ronit I. Yarden, Moshe Zvi Papa · 2006 · Molecular Cancer Therapeutics
  31. The Antiproliferative Response of Indole-3-Carbinol in Human Melanoma Cells Is Triggered by an Interaction with NEDD4-1 and Disruption of Wild-Type PTEN Degradation
    Ida Aronchik, Aishwarya Kundu, Jeanne G. Quirit, Gary L. Firestone · 2014 · Molecular Cancer Research
  32. Inhibition of AKT survival pathway by a small molecule inhibitor in human endometrial cancer cells
    Xingyi Jin, Dana R. Gossett, Shaomeng Wang, Dajun Yang, Yang Cao, Jason C. Chen, Ribo Guo, R. Kevin Reynolds, Jiayuh Lin · 2004 · British Journal of Cancer
  33. The Flavonoid Apigenin Ameliorates Cisplatin-Induced Nephrotoxicity through Reduction of p53 Activation and Promotion of PI3K/Akt Pathway in Human Renal Proximal Tubular Epithelial Cells
    Sung Min Ju, Jun Gue Kang, Jun Sang Bae, Hyun Ock Pae, Yeoung-Su Lyu, Byung Hun Jeon · 2015 · Evidence-based Complementary and Alternative Medicine
  34. Apoptosis in Parkinson's disease: Is p53 the missing link between genetic and sporadic Parkinsonism?
    Cristine Alvès da Costa, Frédéric Checler · 2010 · Cellular Signalling
  35. Loss of function of DJ-1 triggered by Parkinson's disease-associated mutation is due to proteolytic resistance to caspase-6
    Emilie Giaime, Claire Sunyach, Charlotte Druon, Sabine Scarzello, Guillaume Robert, Sébastien Grosso, Patrick Auberger, Matthew S. Goldberg, Jie Shen, Peter Heutink et al. · 2009 · Cell Death and Differentiation
  36. The prognostic value of PTEN, p53, and beta-catenin in endometrial carcinoma: a prospective immunocytochemical study
    Paulina Athanassiadou, Peter H. Athanassiades, Dimitra Grapsa, Maria Gonidi, Anna Maria Athanassiadou, P.N. STAMATI, Efstratios Patsouris · 2007 · International Journal of Gynecological Cancer
  37. Metallothionein 1G functions as a tumor suppressor in thyroid cancer through modulating the PI3K/Akt signaling pathway
    Jiao Fu, Hongjun Lv, Haixia Guan, Xiaoying Ma, Meiju Ji, Nongyue He, Bingyin Shi, Peng Hou · 2013 · BMC Cancer
  38. MEK-ERK-mediated Phosphorylation of Mdm2 at Ser-166 in Hepatocytes
    Maria Malmlöf, Emilie Annie Roudier, Johan Högberg, Ulla Stenius · 2006 · Journal of Biological Chemistry
  39. Activation of LKB1-Akt Pathway Independent of Phosphoinositide 3-Kinase Plays a Critical Role in the Proliferation of Hepatocellular Carcinoma From Nonalcoholic Steatohepatitis
    Nuria Martínez-López, Marta Varela‐Rey, David Fernández‐Ramos, Ashwin Woodhoo, Mercedes Vázquez–Chantada, Nieves Embade, Luis Espinosa‐Hevia, Javier Bustamante, Luis Antonio Parada, Manuel S. Rodríguez et al. · 2010 · Hepatology
  40. IL-1 and EGF regulate expression of genes important in inflammation and cancer
    Aneta Kasza · 2013 · Cytokine
  41. Acne Transcriptomics: Fundamentals of Acne Pathogenesis and Isotretinoin Treatment
    Bodo Clemens Melnik · 2023 · Cells
  42. MDM2 Is Required for Suppression of Apoptosis by Activated Akt1 in Salivary Acinar Cells
    Kirsten H. Limesand, Kathryn L. Schwertfeger, Steven M. Anderson · 2006 · Molecular and Cellular Biology
  43. MEK-ERK-mediated phosphorylation of Mdm2 at Ser-166 in hepatocytes. Mdm2 IS ACTIVATED IN RESPONSE TO INHIBITED Akt SIGNALING.
    Maria Malmlöf, Emilie Annie Roudier, Johan Högberg, Ulla Stenius · 2016 · Journal of Biological Chemistry
  44. A genome‐wide si RNA screen for regulators of tumor suppressor p53 activity in human non‐small cell lung cancer cells identifies components of the RNA splicing machinery as targets for anticancer treatment
    Ellen Siebring‐van Olst, Maxime Blijlevens, Renée X. de Menezes, Ida H. van der Meulen‐Muileman, Egbert Frederik Smit, Victor W. van Beusechem · 2017 · Molecular Oncology
  45. AP-1 Regulates Cyclin D1 and c-MYC Transcription in an AKT-Dependent Manner in Response to mTOR Inhibition: Role of AIP4/Itch-Mediated JUNB Degradation
    Raffi Vartanian, Janine Masri, Jheralyn Martin, Cheri Cloninger, Brent Holmes, Nicholas Artinian, Alex Funk, Teresa Ruegg, Joseph Gera · 2010 · Molecular Cancer Research
  46. F-box protein FBXO31 directs degradation of MDM2 to facilitate p53-mediated growth arrest following genotoxic stress
    Sunil Kumar Malonia, Parul Dutta, Manas Kumar Santra, Michael R. Green · 2015 · Proceedings of the National Academy of Sciences
  47. MDM2 inhibition rescues neurogenic and cognitive deficits in a mouse model of fragile X syndrome
    Yue Li, Michael E. Stockton, Ismat Bhuiyan, Brian E. Eisinger, Yu Gao, Jessica L. Miller, Anita Bhattacharyya, Xinyu Zhao · 2016 · Science Translational Medicine
  48. The induction of heme oxygenase-1 suppresses heat shock protein 90 and the proliferation of human breast cancer cells through its byproduct carbon monoxide
    Wen‐Ying Lee, Yen‐Chou Chen, Chwen-Ming Shih, Chun‐Mao Lin, Chia‐Hsiung Cheng, Ku‐Chung Chen, Cheng-Wei Lin · 2013 · Toxicology and Applied Pharmacology
  49. Pten Deficiency Activates Distinct Downstream Signaling Pathways in a Tissue-Specific Manner
    Lina I. Yoo, David W. Liu, Sandrine Le Vu, Roderick Terry Bronson, Hong Wu, Junying Yuan · 2006 · Cancer Research
  50. Inhibition of β-TrcP–dependent ubiquitination of p53 by HIV-1 Vpu promotes p53–mediated apoptosis in human T cells
    Sachin Kumar Verma, Amjad Ali, Sakshi Arora, Akhil Chandra Banerjea · 2011 · Blood
  51. Pathological Signaling via Platelet-Derived Growth Factor Receptor α Involves Chronic Activation of Akt and Suppression of p53
    Hetian Lei, Gisela Velez, Andrius Kazlauskas · 2011 · Molecular and Cellular Biology
  52. Mechanistic elements and critical factors of cellular reprogramming revealed by stepwise global gene expression analyses
    Sung Jin Park, Hock Chuan Yeo, Nam‐Young Kang, Hanjo Kim, Joyce Lin, Hyung‐Ho Ha, Marc Vendrell, Jun‐Seok Lee, Yogeswari Chandran, Dong‐Yup Lee et al. · 2014 · Stem Cell Research
  53. The Many Faces of MDM2 Binding Partners
    Maurisa F. Riley, Guillermina Lozano · 2012 · Genes & Cancer
  54. Feedbacks, Bifurcations, and Cell Fate Decision-Making in the p53 System
    Beata Hat, Marek Kochańczyk, Marta N. Bogdał, Tomasz Lipniacki B · 2016 · PLoS Computational Biology
  55. ZNF677 Suppresses Akt Phosphorylation and Tumorigenesis in Thyroid Cancer
    Yujun Li, Qi Yang, Haixia Guan, Bingyin Shi, Meiju Ji, Peng Hou · 2018 · Cancer Research
  56. Taming the PI3K team to hold inflammation and cancer at bay
    Emilio Hirsch, Elisa Ciraolo, Alessandra Ghigo, Carlotta Costa · 2008 · Pharmacology & Therapeutics
  57. Mechanisms of Activation and Regulation of the Heat Shock-Sensitive Signaling Pathways
    Sébastien Ian Nadeau, Jacques Landry · 2007 · Springer eBooks
  58. p53 in the CNS: Perspectives on Development, Stem Cells, and Cancer
    Susan M. Mendrysa, Sara Ghassemifar, Reem A. Malek · 2011 · Genes & Cancer
  59. AKT‐dependent phosphorylation of Niban regulates nucleophosmin‐ and MDM2‐mediated p53 stability and cell apoptosis
    Haitao Ji, Zhiyong Ding, David H. Hawke, Dongming Xing, Bing‐Hua Jiang, Gordon Brent Mills, Zhimin Lu · 2012 · EMBO Reports
  60. Postconditioning by Volatile Anesthetics: Salvaging Ischemic Myocardium at Reperfusion by Activation of Prosurvival Signaling
    Paul S. Pagel · 2008 · Journal of Cardiothoracic and Vascular Anesthesia
  61. Targeting AKT with costunolide suppresses the growth of colorectal cancer cells and induces apoptosis in vitro and in vivo
    Hai Huang, Song Park, Haibo Zhang, Sijun Park, Wookbong Kwon, Enugyung Kim, Xiujuan Zhang, Soyoung Jang, Duhak Yoon, Seong‐Kyoon Choi et al. · 2021 · Journal of Experimental & Clinical Cancer Research
  62. Mdm2 in growth signaling and cancer
    Yaara Levav-Cohen, Sue Haupt, Ygal Haupt · 2005 · Growth Factors
  63. Apoptosis Inhibitor ARC Promotes Breast Tumorigenesis, Metastasis, and Chemoresistance
    Christina M. Medina-Ramirez, Sumanta Goswami, Т. А. Смирнова, Daniel G. Bamira, Benjamin Benson, Neal J. Ferrick, Jeffrey E. Segall, Jeffrey W. Pollard, Richard N. Kitsis · 2011 · Cancer Research
  64. Phosphoinositides: multipurpose cellular lipids with emerging roles in cell death
    Thanh Kha Phan, Scott A. Williams, Guneet K. Bindra, Fung T. Lay, Ivan K. H. Poon, Mark D. Hulett · 2019 · Cell Death and Differentiation
  65. FBP1 controls liver cancer evolution from senescent MASH hepatocytes
    Li Gu, Yahui Zhu, Shuvro Prokash Nandi, Maiya Lee, Kosuke Watari, Breanna Bareng, Masafumi Ohira, Yuxiao Liu, Sadatsugu Sakane, Rodrigo Carlessi et al. · 2025 · Nature
  66. Clinical utility of anti-p53auto-antibody: Systematic review and focus on colorectal cancer
    Aravind Suppiah · 2013 · World Journal of Gastroenterology
  67. p53 and Notch signaling in chronic lymphocytic leukemia: clues to identifying novel therapeutic strategies
    R. Gitendra Wickremasinghe, Archie Prentice, Andrew J. Steele · 2011 · Leukemia
  68. RasGRP1 stimulation enhances ubiquitination and endocytosis of the sodium-chloride cotransporter
    Benjamin S. Ko, Erik‐Jan Kamsteeg, Leslie L. Cooke, Lauren Moddes, Peter M.T. Deen, Robert S. Hoover · 2010 · American Journal of Physiology-Renal Physiology
  69. Shikonin Inhibits Thyroid Cancer Cell Growth and Invasiveness Through Targeting Major Signaling Pathways
    Qi Yang, Meiju Ji, Haixia Guan, Bingyin Shi, Peng Hou · 2013 · The Journal of Clinical Endocrinology & Metabolism
  70. The Protective Effect of FGF21 on Diabetes-Induced Male Germ Cell Apoptosis Is Associated With Up-Regulated Testicular AKT and AMPK/Sirt1/PGC-1α Signaling
    Xin Mei Jiang, Jun Chen, Chi Zhang, Zhiguo Zhang, Yi Tan, Wenke Feng, Melissa E. Skibba, Ying Xin, Lu Cai · 2015 · Endocrinology
  71. Tied Up in Loops: Positive and Negative Autoregulation of p53
    Xin Lü · 2009 · Cold Spring Harbor Perspectives in Biology
  72. Gramine attenuates EGFR-mediated inflammation and cell proliferation in oral carcinogenesis via regulation of NF-κB and STAT3 signaling
    Arun Kumar Ramu, Suresh Kathiresan, Hemavardhini Ramadoss, Anandhi Nallu, Ramachandran Kaliyan, Theerthu Azhamuthu · 2017 · Biomedicine & Pharmacotherapy
  73. Sodium dichloroacetate (DCA) reduces apoptosis in colorectal tumor hypoxia
    Siranoush Shahrzad, Kristen Lacombe, Una Adamcic, Kanwal Minhas, Brenda Lynn Coomber · 2010 · Cancer Letters
  74. Natural Product MDM2 Inhibitors: Anticancer Activity and Mechanisms of Action
    Jiang‐Jiang Qin, Subhasree Ashok Nag, Sukesh Voruganti, W. Wang, Ruifeng Zhang · 2012 · Current Medicinal Chemistry
  75. Negative Regulation of p53 by the Long Isoform of ErbB3 Binding Protein Ebp1 in Brain Tumors
    Chung Kwon Kim, Truong L.X. Nguyen, Kyeung Min Joo, Do‐Hyun Nam, Jihye Park, Kyunghoon Lee, Sung Woo Cho, Jee‐Yin Ahn · 2010 · Cancer Research
  76. Unravelling mechanisms of cisplatin sensitivity and resistance in testicular cancer
    Roelof Koster, Marcel A.T.M. van Vugt, Hetty Timmer‐Bosscha, Jourik A. Gietema, Steven de Jong · 2013 · Expert Reviews in Molecular Medicine
  77. p53 ubiquitination by Mdm2: A never ending tail?
    Amanda S. Coutts, Cassandra Adams, Nicholas Barrie La Thangue · 2009 · DNA repair
  78. Clinical Development of AKT Inhibitors and Associated Predictive Biomarkers to Guide Patient Treatment in Cancer Medicine
    Niamh Coleman, Justin Tyler Moyers, Alice Harbery, Igor Vivanco, Timothy Anthony Yap · 2021 · Pharmacogenomics and Personalized Medicine
  79. Role of Akt/protein kinase B in the activity of transcriptional coactivator p300
    Jihong Chen, Sabina S. Halappanavar, Jonathan R. St‐Germain, Benjamin K. Tsang, Qiao Li · 2004 · Cellular and Molecular Life Sciences
  80. Chlamydia trachomatis Prevents Apoptosis Via Activation of PDPK1-MYC and Enhanced Mitochondrial Binding of Hexokinase II
    Munir A. Al‐Zeer, Audrey Xavier, Mohammad Abu Lubad, Janine Sigulla, Mirjana Kessler, ROBERT M. HURWITZ, Thomas F. Meyer · 2017 · EBioMedicine
  81. The MEK1/2 Inhibitor Pimasertib Enhances Gemcitabine Efficacy in Pancreatic Cancer Models by Altering Ribonucleotide Reductase Subunit-1 (RRM1)
    Francesca Vena, Eleonora Li Causi, Manuel Rodriguez‐Justo, Samantha M. Goodstal, Thorsten Hagemann, John Anthony Hartley, Daniel Hochhauser · 2015 · Clinical Cancer Research
  82. HMG‐CoA reductase inhibitors, statins, induce phosphorylation of Mdm2 and attenuate the p53 response to DNA damage
    Gerd Pääjärvi, Emilie Annie Roudier, Milita Crisby, Johan Högberg, Ulla Stenius · 2004 · The FASEB Journal
  83. Epigenetic Alteration of PRKCDBP in Colorectal Cancers and Its Implication in Tumor Cell Resistance to TNFα-Induced Apoptosis
    Jinhee Lee, Min Ju Kang, Hye-Yeon Han, Min-Goo Lee, Seong-In Jeong, Byung–Kyu Ryu, Tae-Kyu Ha, Nam-Goo Her, Jikhyon Han, Sun Jin Park et al. · 2011 · Clinical Cancer Research
  84. Influence of zinc deficiency on Akt-Mdm2-p53 and Akt-p21 signaling axes in normal and malignant human prostate cells
    Tina Han, Norberta W. Schoene, Kai Y Lei · 2009 · American Journal of Physiology-Cell Physiology
  85. MicroRNA-498 promotes proliferation and migration by targeting the tumor suppressor PTEN in breast cancer cells
    Chengsen Chai, Hong Wu, Benfan Wang, David D. Eisenstat, Roger P. Leng · 2018 · Carcinogenesis
  86. Fundamental insights into the interaction between telomerase/TERT and intracellular signaling pathways
    Somayyeh Ghareghomi, Shahin Ahmadian, Nosratollah Zarghami, Houman Kahroba · 2020 · Biochimie
  87. p53 down‐regulation: a new molecular mechanism involved in ischaemic preconditioning
    Mihaela M. Mocanu, Derek M. Yellon · 2003 · FEBS Letters
  88. Mapping genetic alterations causing chemoresistance in cancer: identifying the roads by tracking the drivers
    Per Eystein Lønning, Stian Knappskog · 2013 · Oncogene
  89. Expression of SPRR3 is associated with tumor cell proliferation in less advanced stages of breast cancer
    Jin Cheon Kim, Jong Han Yu, Yoon Kyung Cho, Choon Sik Jung, Sei Hyun Ahn, Gyungyub Gong, Yong Sung Kim, Dong‐Hyung Cho · 2011 · Breast Cancer Research and Treatment
  90. The PTEN-AKT-mTOR/RICTOR Pathway in Nasal Natural Killer Cell Lymphoma Is Activated by miR-494-3p via PTEN But Inhibited by miR-142-3p via RICTOR
    Hao-Hui Chen, Weiting Huang, Liwei Yang, Chung‐Wu Lin · 2015 · American Journal Of Pathology
  91. Roles of TP53 in determining therapeutic sensitivity, growth, cellular senescence, invasion and metastasis
    James Andrew McCubrey, Kvin Lertpiriyapong, Timothy Louis Fitzgerald, Alberto Maria Martelli, Lucio Cocco, Dariusz Rakus, Agnieszka Gizak, Massimo Libra, Melchiorre Cervello, Guiseppe Montalto et al. · 2016 · Advances in Biological Regulation
  92. TIM-1 promotes proliferation and metastasis, and inhibits apoptosis, in cervical cancer through the PI3K/AKT/p53 pathway
    Liuyan Chen, Jilin Qing, Yangyang Xiao, Xiaomei Huang, Yanlin Chi, Zhizhong Chen · 2022 · BMC Cancer
  93. NF-κB1 p50 promotes p53 protein translation through miR-190 downregulation of PHLPP1
    Yonghui Yu, D Zhang, Haishan Huang, Juncheng Li, Mr. Genxi Zhang, Y Wan, Jimin Gao, Chuanshu Huang · 2013 · Oncogene
  94. Modulation of p53 Degradation via MDM2-Mediated Ubiquitylation and the Ubiquitin–Proteasome System during Reperfusion after Stroke: Role of Oxidative Stress
    Atsushi Saito, Takeshi Hayashi, Shuzo Okuno, Tatsuro Nishi, Pak Hoo Chan · 2005 · Journal of Cerebral Blood Flow & Metabolism
  95. Infection of Human Immunodeficiency Virus and Intracellular Viral Tat Protein Exert a Pro-survival Effect in a Human Microglial Cell Line
    Pauline Chugh, Shongshan Fan, Vicente Planelles, Sanjay B. Maggirwar, Stephen Dewhurst, Baek Kim · 2006 · Journal of Molecular Biology
  96. Akt and p53R2, partners that dictate the progression and invasiveness of cancer
    Bahman Yousefi, Nasser Samadi, Yasin Ahmadi · 2014 · DNA repair
  97. Antitumor Activity and Induction of TP53-Dependent Apoptosis toward Ovarian Clear Cell Adenocarcinoma by the Dual PI3K/mTOR Inhibitor DS-7423
    Tomoko Kashiyama, Katsutoshi Oda, Yuji Ikeda, Yoshinobu Shiose, Yasuhide Hirota, Kanako Inaba, Chinami Makii, Reiko Kurikawa, Aki Miyasaka, Takahiro Koso et al. · 2014 · PLoS ONE
  98. RET/PTC (Rearranged in Transformation/Papillary Thyroid Carcinomas) Tyrosine Kinase Phosphorylates and Activates Phosphoinositide-Dependent Kinase 1 (PDK1): An Alternative Phosphatidylinositol 3-Kinase-Independent Pathway to Activate PDK1
    Dong Wook Kim, Jung Hwan Hwang, Jae Mi Suh, Hohyun Kim, Jung Hun Song, Eun Suk Hwang, Il Young Hwang, Ki Cheol Park, Hyo Kyun Chung, Jin‐Man Kim et al. · 2003 · Molecular Endocrinology
  99. Activated Akt expression in breast cancer: Correlation with p53, Hdm2 and patient outcome
    S.B. Vestey, C. Sen, Caroline Jane Calder, Claire M. Perks, Massimo N. Pignatelli, Zoë Winters · 2005 · European Journal of Cancer
  100. Nitric oxide activated by p38 and NF-κB facilitates apoptosis and cell cycle arrest under oxidative stress in evodiamine-treated human melanoma A375-S2 cells
    Jia Ying Yang, WU Li-jun, Shin‐ichi Tashiro, Satoshi Onodera, Takashi Ikejima · 2008 · Free Radical Research